The ability to provide treatment for gynecological cancer and pelvic floor disorders concurrently has the potential to improve the quality of life for gynecological oncology patients, a recent study found. A pelvic floor dysfunction screening questionnaire was given to new patients presenting to a university-based gynecological oncology practice between August 1, 2010, and August 31, 2012. Those indicating symptoms related to pelvic floor dysfunction were offered urogynecological evaluations. Researchers found:
- Of 546 survey reviews, 236 (42.0%) patients reported being bothered by pelvic floor dysfunction symptoms.
- However, only 6.7% wanted a referral for a urogynecological evaluation, and 93.2% declined an evaluation.
- The most frequently cited barrier to care among patients reporting moderate to severe bother from pelvic floor symptoms was feeling overwhelmed with the current medical situation (28%).
- Other barriers included a previous evaluation (14%), financial concerns (6.9%), and the belief that oncological treatment would cure pelvic floor symptoms (6%).
Doyle PJ, Thomas SG, Buchsbaum GM. Barriers to urogynecological care in a population of gynecological oncology patients. [Published online ahead of print November 17, 2016]. Int Urogynecol J. doi:10.1007/s00192-016-3204-4.
This Week's Must Reads
Must Reads in Gynecologic Cancer
Maternal Factors in Cervical Cancer Prevention, Womens Health Issues; ePub 2019 Jan 10; Charlton, et al
Combined Gynecologic Ca & Pelvic Floor Dysfunction Surgery, Female Pelvic Med Reconstr Surg; ePub 2018 Oct 22; McConnell, et al